Baseline neutrophil-to-lymphocyte ratio in patients with advanced melanoma treated with immune checkpoint inhibitors: reply from the authors.

Baseline neutrophil-to-lymphocyte ratio in patients with advanced melanoma treated with immune checkpoint inhibitors: reply from the authors. Br J Dermatol. 2018 May 07;: Authors: Fujisawa Y PMID: 29733122 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29733122?dopt=Abstract

Source: The British Journal of Dermatology - May 7, 2018 Category: Dermatology Authors: Fujisawa Y Tags: Br J Dermatol Source Type: research

More News: Dermatology | Melanoma | Skin | Skin Cancer | UK Health